![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PIK3R4 |
Gene summary for PIK3R4 |
![]() |
Gene information | Species | Human | Gene symbol | PIK3R4 | Gene ID | 30849 |
Gene name | phosphoinositide-3-kinase regulatory subunit 4 | |
Gene Alias | VPS15 | |
Cytomap | 3q22.1 | |
Gene Type | protein-coding | GO ID | GO:0000910 | UniProtAcc | Q99570 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
30849 | PIK3R4 | CCI_1 | Human | Cervix | CC | 1.31e-04 | 2.92e-01 | 0.528 |
30849 | PIK3R4 | CCI_2 | Human | Cervix | CC | 3.74e-10 | 6.75e-01 | 0.5249 |
30849 | PIK3R4 | CCI_3 | Human | Cervix | CC | 4.50e-13 | 6.31e-01 | 0.516 |
30849 | PIK3R4 | LZE2T | Human | Esophagus | ESCC | 2.12e-02 | 3.79e-01 | 0.082 |
30849 | PIK3R4 | LZE4T | Human | Esophagus | ESCC | 2.88e-09 | 3.18e-01 | 0.0811 |
30849 | PIK3R4 | LZE7T | Human | Esophagus | ESCC | 1.49e-08 | 4.99e-01 | 0.0667 |
30849 | PIK3R4 | LZE8T | Human | Esophagus | ESCC | 3.40e-02 | 1.20e-01 | 0.067 |
30849 | PIK3R4 | LZE24T | Human | Esophagus | ESCC | 5.37e-03 | 1.56e-01 | 0.0596 |
30849 | PIK3R4 | P1T-E | Human | Esophagus | ESCC | 3.17e-04 | 2.41e-01 | 0.0875 |
30849 | PIK3R4 | P2T-E | Human | Esophagus | ESCC | 8.93e-35 | 6.01e-01 | 0.1177 |
30849 | PIK3R4 | P4T-E | Human | Esophagus | ESCC | 9.97e-10 | 2.18e-01 | 0.1323 |
30849 | PIK3R4 | P5T-E | Human | Esophagus | ESCC | 3.67e-07 | 9.39e-02 | 0.1327 |
30849 | PIK3R4 | P8T-E | Human | Esophagus | ESCC | 3.77e-11 | 2.33e-01 | 0.0889 |
30849 | PIK3R4 | P9T-E | Human | Esophagus | ESCC | 8.65e-10 | 1.40e-01 | 0.1131 |
30849 | PIK3R4 | P10T-E | Human | Esophagus | ESCC | 1.62e-15 | 2.81e-01 | 0.116 |
30849 | PIK3R4 | P12T-E | Human | Esophagus | ESCC | 2.41e-11 | 2.59e-01 | 0.1122 |
30849 | PIK3R4 | P15T-E | Human | Esophagus | ESCC | 1.29e-13 | 3.20e-01 | 0.1149 |
30849 | PIK3R4 | P16T-E | Human | Esophagus | ESCC | 7.35e-15 | 3.23e-01 | 0.1153 |
30849 | PIK3R4 | P20T-E | Human | Esophagus | ESCC | 6.36e-14 | 3.05e-01 | 0.1124 |
30849 | PIK3R4 | P21T-E | Human | Esophagus | ESCC | 5.52e-15 | 3.29e-01 | 0.1617 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00725949 | Cervix | CC | establishment of protein localization to organelle | 99/2311 | 422/18723 | 1.23e-10 | 2.11e-08 | 99 |
GO:007149610 | Cervix | CC | cellular response to external stimulus | 78/2311 | 320/18723 | 1.82e-09 | 1.98e-07 | 78 |
GO:003367410 | Cervix | CC | positive regulation of kinase activity | 101/2311 | 467/18723 | 8.66e-09 | 7.22e-07 | 101 |
GO:00316689 | Cervix | CC | cellular response to extracellular stimulus | 59/2311 | 246/18723 | 3.03e-07 | 1.24e-05 | 59 |
GO:000660510 | Cervix | CC | protein targeting | 68/2311 | 314/18723 | 2.17e-06 | 6.55e-05 | 68 |
GO:003166710 | Cervix | CC | response to nutrient levels | 92/2311 | 474/18723 | 5.80e-06 | 1.42e-04 | 92 |
GO:00092678 | Cervix | CC | cellular response to starvation | 39/2311 | 156/18723 | 1.04e-05 | 2.32e-04 | 39 |
GO:00425948 | Cervix | CC | response to starvation | 46/2311 | 197/18723 | 1.24e-05 | 2.59e-04 | 46 |
GO:00316698 | Cervix | CC | cellular response to nutrient levels | 49/2311 | 215/18723 | 1.32e-05 | 2.68e-04 | 49 |
GO:00726655 | Cervix | CC | protein localization to vacuole | 20/2311 | 67/18723 | 1.12e-04 | 1.40e-03 | 20 |
GO:00162367 | Cervix | CC | macroautophagy | 58/2311 | 291/18723 | 1.40e-04 | 1.70e-03 | 58 |
GO:00513021 | Cervix | CC | regulation of cell division | 39/2311 | 177/18723 | 2.05e-04 | 2.33e-03 | 39 |
GO:00431127 | Cervix | CC | receptor metabolic process | 37/2311 | 166/18723 | 2.31e-04 | 2.58e-03 | 37 |
GO:00009107 | Cervix | CC | cytokinesis | 37/2311 | 173/18723 | 5.40e-04 | 5.23e-03 | 37 |
GO:00070347 | Cervix | CC | vacuolar transport | 34/2311 | 157/18723 | 7.03e-04 | 6.40e-03 | 34 |
GO:00066235 | Cervix | CC | protein targeting to vacuole | 12/2311 | 37/18723 | 1.15e-03 | 9.39e-03 | 12 |
GO:0032465 | Cervix | CC | regulation of cytokinesis | 22/2311 | 92/18723 | 1.55e-03 | 1.20e-02 | 22 |
GO:00726665 | Cervix | CC | establishment of protein localization to vacuole | 14/2311 | 49/18723 | 1.84e-03 | 1.37e-02 | 14 |
GO:0072594110 | Esophagus | ESCC | establishment of protein localization to organelle | 311/8552 | 422/18723 | 3.02e-32 | 2.13e-29 | 311 |
GO:001623617 | Esophagus | ESCC | macroautophagy | 216/8552 | 291/18723 | 1.94e-23 | 4.57e-21 | 216 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501018 | Cervix | CC | Alzheimer disease | 113/1267 | 384/8465 | 9.67e-14 | 3.92e-12 | 2.32e-12 | 113 |
hsa0501618 | Cervix | CC | Huntington disease | 94/1267 | 306/8465 | 8.49e-13 | 3.06e-11 | 1.81e-11 | 94 |
hsa0502218 | Cervix | CC | Pathways of neurodegeneration - multiple diseases | 128/1267 | 476/8465 | 2.87e-12 | 9.29e-11 | 5.50e-11 | 128 |
hsa0501418 | Cervix | CC | Amyotrophic lateral sclerosis | 103/1267 | 364/8465 | 1.79e-11 | 4.47e-10 | 2.64e-10 | 103 |
hsa0513120 | Cervix | CC | Shigellosis | 69/1267 | 247/8465 | 7.64e-08 | 1.03e-06 | 6.10e-07 | 69 |
hsa0501716 | Cervix | CC | Spinocerebellar ataxia | 35/1267 | 143/8465 | 1.77e-03 | 7.21e-03 | 4.26e-03 | 35 |
hsa0501019 | Cervix | CC | Alzheimer disease | 113/1267 | 384/8465 | 9.67e-14 | 3.92e-12 | 2.32e-12 | 113 |
hsa0501619 | Cervix | CC | Huntington disease | 94/1267 | 306/8465 | 8.49e-13 | 3.06e-11 | 1.81e-11 | 94 |
hsa0502219 | Cervix | CC | Pathways of neurodegeneration - multiple diseases | 128/1267 | 476/8465 | 2.87e-12 | 9.29e-11 | 5.50e-11 | 128 |
hsa0501419 | Cervix | CC | Amyotrophic lateral sclerosis | 103/1267 | 364/8465 | 1.79e-11 | 4.47e-10 | 2.64e-10 | 103 |
hsa05131110 | Cervix | CC | Shigellosis | 69/1267 | 247/8465 | 7.64e-08 | 1.03e-06 | 6.10e-07 | 69 |
hsa0501717 | Cervix | CC | Spinocerebellar ataxia | 35/1267 | 143/8465 | 1.77e-03 | 7.21e-03 | 4.26e-03 | 35 |
hsa05014210 | Esophagus | ESCC | Amyotrophic lateral sclerosis | 266/4205 | 364/8465 | 1.31e-20 | 2.20e-18 | 1.13e-18 | 266 |
hsa05016210 | Esophagus | ESCC | Huntington disease | 226/4205 | 306/8465 | 1.38e-18 | 8.72e-17 | 4.46e-17 | 226 |
hsa05022210 | Esophagus | ESCC | Pathways of neurodegeneration - multiple diseases | 318/4205 | 476/8465 | 6.10e-15 | 2.04e-13 | 1.05e-13 | 318 |
hsa05010210 | Esophagus | ESCC | Alzheimer disease | 263/4205 | 384/8465 | 1.80e-14 | 5.47e-13 | 2.80e-13 | 263 |
hsa05131211 | Esophagus | ESCC | Shigellosis | 176/4205 | 247/8465 | 2.27e-12 | 4.01e-11 | 2.05e-11 | 176 |
hsa0414010 | Esophagus | ESCC | Autophagy - animal | 101/4205 | 141/8465 | 7.60e-08 | 6.21e-07 | 3.18e-07 | 101 |
hsa0501728 | Esophagus | ESCC | Spinocerebellar ataxia | 94/4205 | 143/8465 | 6.77e-05 | 2.90e-04 | 1.48e-04 | 94 |
hsa041362 | Esophagus | ESCC | Autophagy - other | 23/4205 | 32/8465 | 8.99e-03 | 2.14e-02 | 1.09e-02 | 23 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PIK3R4 | deletion | Frame_Shift_Del | novel | c.514_532delNNNNNNNNNNNNNNNNNNN | p.Pro172ThrfsTer35 | p.P172Tfs*35 | Q99570 | protein_coding | TCGA-73-4666-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD | ||
PIK3R4 | insertion | Frame_Shift_Ins | novel | c.818_819insT | p.Glu275Ter | p.E275* | Q99570 | protein_coding | TCGA-56-8305-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | ||
PIK3R4 | insertion | Frame_Shift_Ins | novel | c.2169_2170insTTCGCATTTAAAT | p.Val724PhefsTer11 | p.V724Ffs*11 | Q99570 | protein_coding | TCGA-56-8504-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | ||
PIK3R4 | SNV | Missense_Mutation | novel | c.1270N>T | p.His424Tyr | p.H424Y | Q99570 | protein_coding | tolerated(0.32) | benign(0.043) | TCGA-BA-6868-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | carboplatin | PD |
PIK3R4 | SNV | Missense_Mutation | c.3329N>G | p.Ser1110Cys | p.S1110C | Q99570 | protein_coding | deleterious(0) | possibly_damaging(0.85) | TCGA-BA-A6DG-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
PIK3R4 | SNV | Missense_Mutation | novel | c.602G>A | p.Arg201His | p.R201H | Q99570 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-BB-A5HY-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
PIK3R4 | SNV | Missense_Mutation | novel | c.1981G>T | p.Ala661Ser | p.A661S | Q99570 | protein_coding | tolerated(0.18) | benign(0.125) | TCGA-CN-6010-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
PIK3R4 | SNV | Missense_Mutation | novel | c.3581C>T | p.Pro1194Leu | p.P1194L | Q99570 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CR-7399-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PIK3R4 | SNV | Missense_Mutation | novel | c.826C>G | p.Gln276Glu | p.Q276E | Q99570 | protein_coding | deleterious(0.05) | benign(0.043) | TCGA-CV-5436-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
PIK3R4 | SNV | Missense_Mutation | novel | c.558C>G | p.Phe186Leu | p.F186L | Q99570 | protein_coding | deleterious(0) | possibly_damaging(0.623) | TCGA-CV-7089-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
30849 | PIK3R4 | DRUGGABLE GENOME, SERINE THREONINE KINASE, KINASE, PHOSPHATIDYLINOSITOL 3 KINASE, ENZYME | inhibitor | PI-103 | PI-103 | |
30849 | PIK3R4 | DRUGGABLE GENOME, SERINE THREONINE KINASE, KINASE, PHOSPHATIDYLINOSITOL 3 KINASE, ENZYME | inhibitor | BYL719 | ALPELISIB | |
30849 | PIK3R4 | DRUGGABLE GENOME, SERINE THREONINE KINASE, KINASE, PHOSPHATIDYLINOSITOL 3 KINASE, ENZYME | inhibitor | BYL719 | ALPELISIB | |
30849 | PIK3R4 | DRUGGABLE GENOME, SERINE THREONINE KINASE, KINASE, PHOSPHATIDYLINOSITOL 3 KINASE, ENZYME | inhibitor | BUPARLISIB HYDROCHLORIDE | ||
30849 | PIK3R4 | DRUGGABLE GENOME, SERINE THREONINE KINASE, KINASE, PHOSPHATIDYLINOSITOL 3 KINASE, ENZYME | inhibitor | PX-866 | SONOLISIB | |
30849 | PIK3R4 | DRUGGABLE GENOME, SERINE THREONINE KINASE, KINASE, PHOSPHATIDYLINOSITOL 3 KINASE, ENZYME | inhibitor | GDC-0941 | PICTILISIB | |
30849 | PIK3R4 | DRUGGABLE GENOME, SERINE THREONINE KINASE, KINASE, PHOSPHATIDYLINOSITOL 3 KINASE, ENZYME | inhibitor | PKI-587 | GEDATOLISIB | |
30849 | PIK3R4 | DRUGGABLE GENOME, SERINE THREONINE KINASE, KINASE, PHOSPHATIDYLINOSITOL 3 KINASE, ENZYME | inhibitor | BEZ235 | DACTOLISIB | |
30849 | PIK3R4 | DRUGGABLE GENOME, SERINE THREONINE KINASE, KINASE, PHOSPHATIDYLINOSITOL 3 KINASE, ENZYME | inhibitor | GSK2126458 | OMIPALISIB | |
30849 | PIK3R4 | DRUGGABLE GENOME, SERINE THREONINE KINASE, KINASE, PHOSPHATIDYLINOSITOL 3 KINASE, ENZYME | inhibitor | SF1126 |
Page: 1 2 3 |